Sekhar Konjeti

Thyroid cancer paper lands national recognition

Team’s potential lung cancer therapy lands award from SBIR

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.

Targeting tumor “supply lines”

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.


Antioxidant genes keep stomach moving

Antioxidant genes may be good targets for treating a stomach disorder that affects up to 40 percent of patients with diabetes.